Transcend Auto vs Commercially Available Device Clinical Evaluation for Treatment of Obstructive Sleep Apnea (OSA)
NCT ID: NCT01799265
Last Updated: 2025-01-13
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
41 participants
INTERVENTIONAL
2013-02-27
2013-06-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Precision Health and Smart Telerehabilitation in OSA
NCT07254026
Comparison of Two Techniques of Combination Therapy for Treatment of Obstructive Sleep Apnea (OSA)
NCT04029311
A Randomized Study to Compare Polysomnography With Overnight Home Oximetry and Auto - CPAP for Sleep Apnea
NCT00254059
The Influences of Intervention With Home-based Recovery Activity in Obstructive Sleep Apnea Syndrome
NCT02278094
Comparison Study Using APAP With and Without SensAwake in Patients With OSA and PTSD
NCT02549508
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Transcend followed by REMstar
The patient will receive treatment with Transcend during the first night sleep study, followed by treatment with the REMstar on the second night.
Somnetics Transcend Auto
Respironics REMstar Auto with C-Flex
REMstar followed by Transcend
The patient will receive treatment with REMstar during the first night sleep study followed by treatment with Transcend on the second night.
Somnetics Transcend Auto
Respironics REMstar Auto with C-Flex
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Somnetics Transcend Auto
Respironics REMstar Auto with C-Flex
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of obstructive sleep apnea
* Presently using CPAP or APAP therapy
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Somnetics International, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric Powell, PhD RPSGT
Role: PRINCIPAL_INVESTIGATOR
Sleep Therapy and Research Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Northwind Lung Specialists and Sleep Center
Coon Rapids, Minnesota, United States
Whitney Sleep Center
Plymouth, Minnesota, United States
Sleep Therapy and Research Center
San Antonio, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
800383
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.